Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Somerset Pharmaceuticals

1986 FOUNDED
M&A STATUS
2ndary - Private LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of pharmaceutical products. The company is engaged in the clinical development of a selegiline transdermal system for the treatment of several indications, including Alzheimer's disease, depression and parkinson's disease. It also offers pharmaceutical research and development services.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 22202 North West Shore Boulevard
  • Suite 450
  • Tampa, FL 33607
  • United States

Somerset Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Somerset Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Somerset Pharmaceuticals Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Somerset Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Somerset Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Mel Sharoky President & Chief Executive Officer